SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes cGMP inspection at manufacturing facility of Marksans Pharma’s arm

28 Apr 2025 Evaluate

United States Food and Drug Administration (USFDA) has completed a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility of Marksans Pharma’s wholly owned subsidiary Time-Cap Laboratories, Inc. located at 7, Michael Avenue, Farmingdale, New York, USA (the Subsidiary) from April 16 2025 to April 24, 2025.

On conclusion of the inspection, the Subsidiary has received 1 inspectional observation in Form 483. There is no data integrity observation. The Subsidiary will work closely with the USFDA and is committed to address the observation comprehensively within the stipulated time.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.


Marksans Pharma Share Price

204.65 6.75 (3.41%)
11-May-2026 13:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1873.00
Dr. Reddys Lab 1293.10
Cipla 1321.20
Zydus Lifesciences 946.90
Lupin 2264.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×